Document is current

Article History

Received: 7 November 2022

Accepted: 16 February 2023

First Online: 7 March 2023

Declarations

:

: Not applicable.

: Not applicable.

: Paul Feuerstadt; Ferring/Rebiotix: Consulting, Speakers bureau, SERES Therapeutics: Advisory Board, Speakers bureau, Takeda Pharmaceuticals: Advisory Board, Speakers bureau. Nicolette Theriault none; Glenn Tillotson; consultant to Ferring Pharmaceuticals, Spero Pharmaceuticals and Hikma Pharmaceuticals.